Supplementary Table S1. from Multi-Maintenance Olaparib Therapy in Relapsed, Germline <i>BRCA1/2</i>-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II TrialRobert D. Morgan,Andrew R. Clamp,Daniel J. White,Marcus Price,George J. Burghel,W. David J. Ryder,Reem D. Mahmood,Alexander D. Murphy,Jurjees Hasan,Claire L. Mitchell,Zena Salih,Chelsey Wheeler,Emma Buckley,Joanna Truelove,Georgia King,Yasmina Ainaoui,Sanjeev S. Bhaskar,Joseph Shaw,D. Gareth R. Evans,Bedirhan Kilerci,Simon P. Pearce,Gerard Brady,Caroline Dive,James P.B. O'Connor,Andrew J. Wallace,Dominic G. Rothwell,Richard J. Edmondson,Gordon C. Jaysoncrossref（2023）引用 0|浏览14暂无评分摘要Serious adverse events.更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
